International Society for Infectious Diseases Executive Committee Publications Committee
نویسندگان
چکیده
ed/Indexed by: MEDLINE http://intl.elsevierhealth.com/journals/ijid/ PL = Plenary P = Poster Presentations S = Symposium Saturday, March 6, 2004 Session 38 Mycoses (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S132 Session 39 Nosocomial Infections and Infection Control (P) . . . . . . . . . . . . . . . . . . . S134 Session 40 Parasitic Infections I: Systemic Parasitic Infections (P) . . . . . . . . . . . . . . S142 Session 41 Surgical, Obstetric, and Gynecologic Infections (P) . . . . . . . . . . . . . . . . . S149 Session 42 Viral Hepatitis (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S151 Session 43 Science Against SARS (S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S158 Session 44 Problems Posed by Newly Identified or Introduced Viruses (S) . . . . . . . . . . S159 Session 45 The Resistant Pneumococcus and Vaccination— Where Are We in 2004? (S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S160 Session 46 Evolving Drug Resistance in Nosocomial Gram-negative Pathogens (S) . . . . . S161 Session 47 Health Impact of Food-Borne Pathogens (S) . . . . . . . . . . . . . . . . . . . . . S162 Session 48 Challenges to the Global Detection and Surveillance of Infectious Diseases (S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S163 Sunday, March 7, 2004 Session 49 Of Flies and Men: The Role of Toll-like Receptors in Innate Immunity (PL) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S165 Session 50 A Hidden Epidemic: The HTLV-I Story in Latin America (PL) . . . . . . . . . . . S165 Session 51 Bioterrorism: Infectious Diseases as Weapons (S) . . . . . . . . . . . . . . . . . . S165 Session 52 Understanding Community-acquired Bacterial Pneumonia in Children (S) . . . S166 Session 53 Challenges to Polio Eradication (S) . . . . . . . . . . . . . . . . . . . . . . . . . . . S167 Session 54 Infectious Diseases Challenges in Latin America (S) . . . . . . . . . . . . . . . . S168 Session 55 Questions and Answers in Invasive Fungal Infections (S) . . . . . . . . . . . . . S169 Session 56 Understanding Biofilms and their Role in Infectious Diseases (S) . . . . . . . . S170 Session 57 Antimicrobials and Antivirals: New Agents, Pharmacokinetics, Mechanisms of Action (P) . . . . . . . . . . . . . . . . . . . . . S171 Session 58 Bacterial Infections II: Gram-positive Bacteria and Vector-borne Diseases (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S178 Session 59 Epidemiology and Public Health III: Parasitic Diseases, Antibiotics, and Nosocomial Infections (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S187 Session 60 Experimental Infections (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S194 Session 61 HIV II: Epidemiology, Prevention, and Opportunistic Infections (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S201 Session 62 Microbiology and Diagnostics III: Gram-negative Bacterial Infections (P) . . . . . . . . . . . . . . . . . . . . . . . . . S211 Session 63 Parasitic Infections II: Helminthic and Protozoan Infections (P) . . . . . . . . S216 Session 64 Vaccines II (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S222 Session 65 Viral Infections (P) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S228 Session 66 The Effects of Antiretroviral Therapy on HIV Prevention: Intended and Unintended Consequences (S) . . . . . . . . . . . . . . . . . . . . . S237 Session 67 Treating Multi-resistant Gram-Positive Cocci: Novel Antimicrobials and Existing Agents (S) . . . . . . . . . . . . . . . . . . . . . S238 Session 68 Controversies and New Developments in the Treatment of CNS Infections (S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S239 Session 69 New Developments in Severe Sepsis (S) . . . . . . . . . . . . . . . . . . . . . . . . S240 Session 70 Current Aspects of Urinary Tract Infection Therapy (S) . . . . . . . . . . . . . . . S241 Session 71 Infectious Diseases Related to Travel (S) . . . . . . . . . . . . . . . . . . . . . . . . S242 Authors Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S243
منابع مشابه
What is new from the Canadian Paediatric Society Committee on Infectious Diseases and Immunization?
University of Alberta and Stollery Children’s Hospital, Edmonton, Alberta Correspondence: Dr Joan Robinson, University of Alberta and Stollery Children’s Hospital, 3-556 ECHA 11405-87 Avenue, Edmonton, Alberta T6G 1C9. Telephone 780-248-5540, fax 888-790-1176, e-mail [email protected] Publications from the Canadian Paediatric Society (CPS) Committee on Infectious Diseases and Immunization aim to ...
متن کاملBiographic and Disclosure Information
John J V McMurray, MD, FRCP, FESC (Work Group CoChair), is Professor of Medical Cardiology at BHF Glasgow Cardiovascular Research Centre and Head of Section of Academic Cardiology at University of Glasgow. Dr McMurray received his medical degree from University of Manchester and completed additional clinical training in Edinburgh, Dundee and Glasgow. He conducts clinical research in a wide span...
متن کاملOptimizing pediatric clinical care and advocacy in an online era: report of the Canadian Paediatric Society Infectious Diseases and Immunization Committee.
OBJECTIVE To help busy FPs find useful current information and keep up to date on pediatric infectious disease and immunization topics by highlighting the work of one excellent source of reliable information in this area, the Canadian Paediatric Society Infectious Diseases and Immunization Committee. COMPOSITION OF THE COMMITTEE Committee members were appointed to represent the Canadian Paedi...
متن کاملDiagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America.
This is the second in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideline. The targeted providers are pediatricians, family practitioners, and internists. The targeted...
متن کاملGUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Community-Acquired Pneumonia in Adults: Guidelines for Management
This is part of the series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of this guideline is to provide assistance to clinicians in the diagnosis and treatment of community-acquired pneumonia. The targeted providers are internists and family practitioners. The targeted groups are immunocompetent adult pa...
متن کاملThe emerging infections network: a new venture for the Infectious Diseases Society of America. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network.
The Infectious Diseases Society of America (IDSA), in cooperation with the Centers for Disease Control and Prevention, has launched an Emerging Infections Network (EIN). This network of infectious diseases consultants was conceived as a sentinel system to monitor new or resurgent infectious diseases in a way that would complement other public health surveillance efforts. A pilot study with 169 ...
متن کامل